Replies to post #281445 on Amarin Corp Plc (AMRN)

[Vegas8ball]

Thanks Tuc

[Invest83838]

Thank You Tucaman

I felt good when I saw Raf's post showing that Vascepa TRx gain was greater than Generic Lovaza TRx gain

But now see your post showing that the Generic Lovaza NRx gain is greater than the Vascepa NRx gain

Bottom Line is that it appears that Vascepa is currently not making much, if any, headway against Generic Lovaza

Is anyone graphing this over the last several years?

It would be great to see some kind of historical comparison.

[Restingzebra]

Thank you Tman. You are awesome. Nice to see an increase no matter how small. Good weekend.

[circuitcity]

Thanks for data always, look forward to the spike when dtc starts.

[Hondo1021]

Thanks tuc. This is an ATH for refills and top 5 for both new and total scripts. Given C-19 and Amarin's appropriately defensive position re: DTC, these are decent numbers. Onward and upward!

[Bluensleepy]

Thanks again.

[tucaman]

Scripts for week ending 06/19/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.


Vascepa
TRx: 87'652 (-0.92%)
NRx: 39'621 (-1.17%)

Generic Lovaza
TRx: 63'083 (-0.92%)
NRx: 30'417 (-0.54%)

[tucaman]

Scripts for week ending 09/04/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.


Vascepa
TRx: 92'208 (-0.84%)
NRx: 42'830 (+0.24%)

Generic Lovaza
TRx: 63'833 (-0.26%)
NRx: 31'417 (+0.00%)